What You Can Learn From Nanosonics After A 34% Fall

Simply Wall St.

Oct 02

If you only looked at Nanosonics’ early bullish and bearish research notes, the story sounded like a tug-of-war between margin expansion and hospital cost pressure. For Nanosonics shareholders, the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sgp.itiger.com/news/2672970127"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2672970127\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2672970127?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/30967672-card/1790918540089","is_english":true,"pubTime":"2026-10-02 13:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2672970127","market":"nz","top_or_hot":-1,"title":"What You Can Learn From Nanosonics After A 34% Fall","media":"Simply Wall St.","content":"<div>\n<p>If you only looked at Nanosonics’ early bullish and bearish research notes, the story sounded like a tug-of-war between margin expansion and hospital cost pressure. For Nanosonics shareholders, the ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/what-you-can-learn-from-nanosonics-after-a-34-fall\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What You Can Learn From Nanosonics After A 34% Fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat You Can Learn From Nanosonics After A 34% Fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-02 13:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/what-you-can-learn-from-nanosonics-after-a-34-fall><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you only looked at Nanosonics’ early bullish and bearish research notes, the story sounded like a tug-of-war between margin expansion and hospital cost pressure. For Nanosonics shareholders, the ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/what-you-can-learn-from-nanosonics-after-a-34-fall\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7126","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/what-you-can-learn-from-nanosonics-after-a-34-fall","article_id":"2672970127","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/30967672-card/1790918540089"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/what-you-can-learn-from-nanosonics-after-a-34-fall","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2672970127","pubTimestamp":1790918540,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you only looked at Nanosonics’ early bullish and bearish research notes, the story sounded like a tug-of-war between margin expansion and hospital cost pressure. For Nanosonics shareholders, the loss over the past year was 34.0%, including dividends. If you had been weighing an investment in October 2025, how much of that eventual hit was hinted at in the starting debate over dependence on trophon and rising regulatory and tariff costs?\nThe easy part of this move is behind Nanosonics. Zero...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7126":"医疗保健用品","BK7503":"科技股","NAN.AU":"NANOSONICS LTD"},"translate_title":"下跌 34% 后您可以从 Nanosonics 中学到什么","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAN.AU":1},"content_text":"If you only looked at Nanosonics’ early bullish and bearish research notes, the story sounded like a tug-of-war between margin expansion and hospital cost pressure. For Nanosonics shareholders, the loss over the past year was 34.0%, including dividends. If you had been weighing an investment in October 2025, how much of that eventual hit was hinted at in the starting debate over dependence on trophon and rising regulatory and tariff costs? The easy part of this move is behind Nanosonics. Zero in on 4 high quality undervalued stocks for companies trading below our estimates. AdvertisementThe Two Nanosonics Stories Investors Had To Weigh The shares cost A$4.31 at the start, and anyone looking at Nanosonics then faced two very different but plausible stories about where the business could head next. On the bullish side, the Narrative pointed to a Fair Value of A$4.63, which is effectively the price implied if automated disinfection kept gaining traction. That view leaned on global demand for infection prevention, recurring consumable revenue and next generation products like trophon3 and trophon2 plus and CORIS. The bearish camp anchored on a Fair Value of A$3.75, a lower implied price built on tougher assumptions. This version stressed hospital cost containment, dependence on trophon, rising regulatory and tariff expenses and the risk that newer disinfection technologies could chip away at Nanosonics’ pricing power. ASX:NAN 1-Year Stock Price Chart What The Nanosonics Results Actually Tested The clearest new fact for Nanosonics shareholders arrived with the August 2026 report. Total revenue moved from A$105.033m in H2 2025 to A$101.662m in H2 2026, and net income slipped from A$10.916m to A$8.192m. Net margin went from 10.4% to 8.1%. That pattern challenged the more optimistic margin expansion story and leaned toward the cautious case on profitability. The lesson is simple. When a thesis leans on rising profitability, track the net margin line first and ask whether it trends toward or away from the original claim in each set of results. What Nanosonics’ Lower Price Is Asking You To Believe Nanosonics now trades at A$2.87, well below where the story began a year ago. The selected Narrative’s Fair Value sits above the current price, based on a view that the infection prevention franchise has more to run than the share chart suggests. The argument leans on expanding automated disinfection, new products like trophon3 and CORIS, and the earnings impact of the buyback. For that higher figure to be reached, a buyer today would need to believe recurring disinfection and subscription revenue keeps compounding from a larger installed base. \"Expansion of automated disinfection solutions and next-generation product launches are driving adoption, recurring revenue, and higher margins globally. Scalable operations and investment in innovation position the company for sustained earnings and margin growth as its product and geographic footprint expands.\" Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there Go Straight To The Source The next headline does not have to be where your research begins. Go straight to the companies and see whether a contrarian opportunity could be taking shape.  Company 1 - 29% below our estimate - supplies commercial vehicle operators relying on specialist parts selection, logistics support and technical problem solving. Company 2 - 17% below our estimate - integrates complex audio visual, electrical and communications systems for large venues, offices and critical control rooms. Company 3 - 37% below our estimate - sells household tech and appliances through combined physical stores, online channels and bundled installation services.  That is three of the list. See the full list of 12 financially solid companies →  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}